MA Cornier D Dabelea TL Hernandez, et al. 2008 The metabolic syndrome Endocr Rev 29 777 822 10.1210/er.2008-0024 1:CAS:528:DC%2BD1MXmt1yjtg%3D%3D 18971485
Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome
DOI 10.1161/01.CIR.0000141736.76561.78
A Prasad AA Quyyumi 2004 Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome Circulation 110 1507 1512 10.1161/01.CIR.0000141736.76561.78 15364819 (Pubitemid 39238031)
(2004)Circulation, vol.110, Issue.11, pp. 1507-1512
1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes
DOI 10.1016/j.febslet.2004.09.027, PII S0014579304011433
M Fujimoto H Masuzaki T Tanaka, et al. 2004 An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes FEBS Lett 576 492 497 10.1016/j.febslet.2004.09. 027 1:CAS:528:DC%2BD2cXovV2iurw%3D 15498586 (Pubitemid 39388651)
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist with Selective PPARγ-Modulating Activity
DOI 10.1161/01.HYP.0000123072.34629.57
SC Benson HA Pershadsingh CI Ho, et al. 2004 Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 993 1002 10.1161/01.HYP. 0000123072.34629.57 1:CAS:528:DC%2BD2cXjt1GmtrY%3D 15007034 (Pubitemid 38579904)
M Clemenz N Frost M Schupp, et al. 2008 Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan Diabetes 57 1405 1413 10.2337/db07-0839 1:CAS:528:DC%2BD1cXlvVKjur8%3D 18184928
Y Li I Kishimoto Y Saito, et al. 2002 Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart Circulation 106 1722 1728 10.1161/01.CIR. 0000029923.57048.61 1:CAS:528:DC%2BD38XntVynsbk%3D 12270869
X Rong Y Li K Ebihara, et al. 2009 An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice J Pharmacol Exp Ther 331 1096 1103 10.1124/jpet.109.157099 1:CAS:528: DC%2BD1MXhsFaqsLvF 19770292
Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice
DOI 10.1016/j.cmet.2005.06.006, PII S1550413105001713
S Neschen K Morino LE Hammond, et al. 2005 Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn- 3-phosphate acyltransferase 1 knockout mice Cell Metab 2 55 65 10.1016/j.cmet.2005.06.006 1:CAS:528:DC%2BD2MXntlCrurY%3D 16054099 (Pubitemid 43239825)